Observational Study to Evaluate the occurrence of Age-Related Macular Degeneration (AMD) in Japanese Patients with genetic deficiency of Cholesteryl Ester Transfer Protein (CETP)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1050230058

Enrollment

Registered

2023-06-25

Start date

2023-09-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with homozygous CETP deficiency

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patients who give written consent by using a ICF approved by the Institutional Review Board or Independent Ethics Committee of the observational study site before starting procedures related to the observational study. 2)Male and female patients who are aged 50 years or older at the time of obtaining written consent 3)Patients with any of the following: a)deficiency of cholesteryl ester transfer protein based on genetic test results b)Patients with a CETP level of less than or equal to 0.5 (microgram/milliliter) who may be diagnosed with a homozygous gene deficiency of cholesteryl ester transfer protein (CETP)

Exclusion criteria

Exclusion criteria: Patients who are unable to undergo ophthalmologic examination

Design outcomes

Primary

Measure	Time frame
occurence of AMD	—

Contacts

Public ContactMariko Shiba

Osaka Medical and Pharmaceutical University Hospital

mariko.shiba@ompu.ac.jp+81-72-683-1221

Outcome results